ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 528,94
0,34%
Dow Jones
38 510,74
-0,20%
DAX
18 027,34
0,04%
Brent Oil
82,96
1,02%
Bitcoin
65 424,39
-1,82%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ArQule Inc (ARQL)

  7. ArQule Inc (ARQL) Actualités

ARQL

ArQule (ARQL)

ArQule Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ARQL
DateHeureSourceTitreSymboleSociété
14/02/202023h35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARQLArQule Inc
14/02/202018h20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARQLArQule Inc
27/01/202019h55Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ARQLArQule Inc
21/01/202012h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARQLArQule Inc
06/01/202017h07PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the FirmNASDAQ:ARQLArQule Inc
12/12/201921h49PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.NASDAQ:ARQLArQule Inc
10/12/201909h02Dow Jones NewsMerck, Sanofi Push To Add Cancer Drugs -- WSJNASDAQ:ARQLArQule Inc
10/12/201901h16Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 4th UpdateNASDAQ:ARQLArQule Inc
09/12/201922h37Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 3rd UpdateNASDAQ:ARQLArQule Inc
09/12/201921h12Dow Jones NewsU.S. Stocks Slip as Trade War Weighs on Chinese ExportsNASDAQ:ARQLArQule Inc
09/12/201920h33Dow Jones NewsBig Drugmakers Push Deeper Into Cancer Treatment -- 2nd UpdateNASDAQ:ARQLArQule Inc
09/12/201917h13Dow Jones NewsMerck to Buy ArQule for $2.7 Billion -- UpdateNASDAQ:ARQLArQule Inc
09/12/201914h05Business WireArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology...NASDAQ:ARQLArQule Inc
09/12/201913h37PR Newswire (US)(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price?NASDAQ:ARQLArQule Inc
09/12/201913h26Dow Jones NewsMerck to Buy ArQule for $2.7 Billion, or $20/ShareNASDAQ:ARQLArQule Inc
09/12/201912h45Business WireMerck to Acquire ArQule, Advancing Leadership in OncologyNASDAQ:ARQLArQule Inc
25/11/201913h00Business WireArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual ...NASDAQ:ARQLArQule Inc
13/11/201913h00Business WireArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019NASDAQ:ARQLArQule Inc
06/11/201915h05Business WireArQule Announces Release of American Society of Hematology Abstract Detailing Results of the Ongoing Phase 1 Study of Reversi...NASDAQ:ARQLArQule Inc
30/10/201915h57Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARQLArQule Inc
30/10/201912h30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARQLArQule Inc
30/10/201912h00Business WireArQule Reports Third Quarter 2019 Financial ResultsNASDAQ:ARQLArQule Inc
29/10/201921h01Business WireArQule Presents Recent Data on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Ther...NASDAQ:ARQLArQule Inc
21/10/201913h00Business WireArQule Announces Preclinical Data Demonstrating Potential of Miransertib (ARQ 092) to Treat PIK3CA-Driven Vascular Malformati...NASDAQ:ARQLArQule Inc
16/10/201913h00Business WireArQule to Report Third Quarter 2019 Financial Results on October 30, 2019NASDAQ:ARQLArQule Inc
16/10/201913h00Business WireArQule Announces Presentations on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets & Cancer T...NASDAQ:ARQLArQule Inc
08/10/201913h00Business Wire ArQule to Present Preclinical Data on Miransertib for the Treatment of Vascular Malformations at the 2019 American Society ...NASDAQ:ARQLArQule Inc
02/10/201913h00Business WireArQule Announces First Patient Dosed in Registrational MOSIAC Trial of Miransertib for the Treatment of Proteus Syndrome & PI...NASDAQ:ARQLArQule Inc
26/09/201913h00Business WireArQule to Present at the 2019 Cantor Global Healthcare Conference on October 3, 2019NASDAQ:ARQLArQule Inc
25/09/201916h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARQLArQule Inc
 Showing the most relevant articles for your search:NASDAQ:ARQL

Dernières Valeurs Consultées

BIT
P225B6
NLBNPIT225B6 20241220 8
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés